IDH1 and neoplasm: Found in ~9% of patients, this mutation impairs tumor cell metabolism and influences overall survival rate – 1.1 years for wild type IDH1 (IDH-wt) compared to 3.8 years for mutant IDH1 (IDH-mut)30-32.